Dr. Peter Fedichev
Ph.D. is Cofounder and Chief Scientific Officer at
Quantum Pharmaceuticals is a technology based drug discovery company. They develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue their own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral, and anti-cancer efficacy.
Peter is a former assistant professor at the Institute for Theoretical Physics (Innsbruck University, Austria). He is author of over 40 scientific papers and earned his Ph.D. from the University of Amsterdam. He worked at the FOM Institute for Molecular and Atomic Physics in Amsterdam and the Institute for Molecular Physics at Russian Research Center “Kurchatov Institute” (Moscow, Russia).
His papers include Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions, Defect-Suppressed Atomic Crystals in an Optical Lattice, Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo, BKT phase transition in a 2D system with long-range dipole-dipole interaction, O(N) continuous electrostatics solvation energies calculation method for biomolecules simulations, and Liquid-liquid phase transition model incorporating evidence for ferroelectric state near the lambda-point anomaly in supercooled water.
View his Facebook page. Read his Google+ profile and his LinkedIn profile. Follow his Twitter feed.